Related Experiment Videos
Structure-based design of amidinophenylurea-derivatives for factor VIIa inhibition
Otmar Klingler1, Hans Matter, Manfred Schudok
1Aventis Pharma Deutschland GmbH, Building G878, D-65926 Frankfurt, Germany. otmar.klinger@aventis.com
Bioorganic & Medicinal Chemistry Letters
|June 19, 2004
Abstract:
The amidinophenylurea scaffold was earlier shown to provide an excellent template for the synthesis of novel and potent inhibitors of the blood coagulation factor VIIa. In this contribution we describe the structure-based design of potent ligands guided by X-ray crystallography, molecular modeling and docking studies. The design and synthetic efforts were directed towards novel modifications to explore the protease binding region close to the S4 subsite.